Details of the Drug Formulaction

General Information of Drug Formulation (ID: F02710)

Formulation Name

Brigatinib 30 mg tablet

Company

Millennium Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Brigatinib	DM7W94S	Anaplastic large cell lymphoma	2A90.A	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Lactose monohydrate	E00393	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	E00208	11177	lubricant
Silicon dioxide	E00670	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent

--------------------